Trinity College Dublin researchers, based at St James’s Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial ‘natural killer’ (NK) immune cell resident in the lungs.
Cybin Announces Closing of Offering of Units Led by One of the Company’s Largest Institutional Shareholders | Psychedelic Invest
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment